Organoid Sample Preparation and Extraction for LC-MS Peptidomics

This protocol describes the peptidomic analysis of organoid lysates, FACS-purified cell populations, and 2D culture secretions by liquid chromatography mass spectrometry (LC-MS). Currently, most peptides are quantified by ELISA, limiting the peptides that can be studied. However, an LC-MS-based appr...

Full description

Saved in:
Bibliographic Details
Published inSTAR protocols Vol. 1; no. 3; p. 100164
Main Authors Miedzybrodzka, Emily L., Foreman, Rachel E., Galvin, Sam G., Larraufie, Pierre, George, Amy L., Goldspink, Deborah A., Reimann, Frank, Gribble, Fiona M., Kay, Richard G.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 18.12.2020
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This protocol describes the peptidomic analysis of organoid lysates, FACS-purified cell populations, and 2D culture secretions by liquid chromatography mass spectrometry (LC-MS). Currently, most peptides are quantified by ELISA, limiting the peptides that can be studied. However, an LC-MS-based approach allows more peptides to be monitored. Our group has previously used LC-MS for tissue peptidomics and secretion of enteroendocrine peptides from primary culture. Now, we extend the use to organoid models. For complete details on the use and execution of this protocol, please refer to Goldspink et al. (2020). [Display omitted] •Preparing organoid cultures, secretions, and FAC-sorted cells for peptidomics•An established pipeline covering peptide extraction, LC-MS, and data analysis•Unambiguous detection of closely related peptide hormones•Semi-quantitative analysis of secreted peptides from stimulated organoid cultures This protocol describes the peptidomic analysis of organoid lysates, FACS-purified cell populations, and 2D culture secretions by liquid chromatography mass spectrometry (LC-MS). Currently, most peptides are quantified by ELISA, limiting the peptides that can be studied. However, an LC-MS-based approach allows more peptides to be monitored. Our group has previously used LC-MS for tissue peptidomics and secretion of enteroendocrine peptides from primary culture. Now, we extend the use to organoid models.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Lead Contact
Present address: Novel Human Genetics, GSK Medicines Research Centre, Stevenage, UK
Present address: Université Paris-Saclay, AgroParisTech, INRAE, UMR PNCA, 75005 Paris, France
Technical Contact
These authors contributed equally
ISSN:2666-1667
2666-1667
DOI:10.1016/j.xpro.2020.100164